Lionheart Acquisition Corp. II: insider trades · United States · SEC (Form 4)

About Lionheart Acquisition Corp. II

Lionheart Acquisition Corp. II (ticker: LCAP) is a U.S.-listed SPAC trading on NASDAQ in the United States. From an equity research perspective, it should be viewed as a capital-markets vehicle rather than a traditional operating company. The company was incorporated in December 2019 and launched its initial public offering in 2020 with the stated purpose of completing a merger, stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more private businesses. Lionheart was sponsored and led by the Lionheart Capital platform in Miami, Florida, with Ophir Sternberg serving as a central sponsor figure. Company filings and corporate materials place the headquarters in Miami, Florida, which ties the issuer to the U.S. financial and entrepreneurial ecosystem. LCAP does not have conventional business lines, products, or services in the way an industrial or consumer issuer would. Its operating model is the SPAC model: raise capital from public investors, hold proceeds in trust, and then identify and negotiate a merger with a private target. As a result, the investment case is driven by sponsor quality, deal pipeline, transaction structure, redemption dynamics, and the timing of any business combination. Historically, the company was initially marketed around a proptech-oriented acquisition thesis, but in July 2021 Lionheart announced a business combination agreement with MSP Recovery, a company focused on Medicare, Medicaid, commercial, and secondary-payer reimbursement recovery using data-driven claims and compliance solutions. That shift illustrates both the flexibility and the uncertainty inherent in SPAC investing. From a competitive standpoint, Lionheart competes primarily with other SPACs and blank-check sponsors rather than with operating peers. Its relative positioning depends on its ability to source an attractive target, secure financing support, and execute a transaction that survives shareholder redemptions and regulatory scrutiny. In May 2022, Lionheart disclosed non-binding term sheets with Cantor Fitzgerald for a forward purchase agreement and a committed equity facility, signaling an effort to support the pending combination with MSP Recovery and strengthen post-closing financing capacity. More recent SEC-related disclosures indicate that LCAP remains associated with Nasdaq listing status and that the company has an initial business combination deadline referenced as June 20, 2026, with potential delisting risk if it does not complete a transaction within the required timeframe. In short, LCAP is best understood as an event-driven NASDAQ SPAC in the United States, where headline risk, SEC filings, and deal execution dominate the investment narrative.